Tate & Lyle PLC
TATE: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|># | LOCK|@w!#S | LOCK|@Y#Tm%R |
Tate & Lyle Earnings: EBITDA Growth Tracking Full-Year Expectations; CP Kelco Acquisition Imminent
Tate & Lyle reported adjusted EBITDA growth of 6% for the first half of fiscal 2025, despite a 7% revenue decline. The full-year guidance was confirmed, and the acquisition of CP Kelco is approaching completion.
